We are live on ! Find out more
SAGE

Sage Therapeutics

Delisted

SAGE was delisted on the 30th of July, 2025.

268 hedge funds and large institutions have $7.6B invested in Sage Therapeutics in 2018 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 114 increasing their positions, 77 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 28

48% more repeat investments, than reductions

Existing positions increased: 114 | Existing positions reduced: 77

17% more funds holding in top 10

Funds holding in top 10: 1214 (+2)

7% more funds holding

Funds holding: 250268 (+18)

5% more call options, than puts

Call options by funds: $61.1M | Put options by funds: $58M

0.51% more ownership

Funds ownership: 103.93%104.44% (+0.51%)

1% less capital invested

Capital invested by funds: $7.65B → $7.6B (-$55.9M)

Holders
268
Holders Change
+18
Holders Change %
+7.2%
% of All Funds
6.14%
Holding in Top 10
14
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+16.67%
% of All Funds
0.32%
New
47
Increased
114
Reduced
77
Closed
28
Calls
$61.1M
Puts
$58M
Net Calls
+$3.17M
Net Calls Change
-$6.35M
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$1.19B +$74.8M +476,305 +7%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$1.09B +$17.4M +110,687 +2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$598M +$9.43M +60,038 +2%
BlackRock
4
BlackRock
New York
$437M -$154M -981,735 -26%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$310M -$45.1M -287,018 -13%
O
6
OppenheimerFunds
New York
$250M +$5.4M +34,389 +2%
Bank of New York Mellon
7
Bank of New York Mellon
New York
$245M +$17.3M +110,134 +8%
BB
8
BB Biotech
Switzerland
$168M +$10.8M +68,934 +7%
State Street
9
State Street
Massachusetts
$156M -$37M -235,772 -19%
JP Morgan Chase
10
JP Morgan Chase
New York
$146M +$33.2M +211,272 +29%
PAI
11
Palo Alto Investors
California
$130M +$2.23M +14,205 +2%
Jennison Associates
12
Jennison Associates
New York
$126M +$2.25M +14,338 +2%
FCM
13
Farallon Capital Management
California
$97.8M +$28.3M +180,000 +40%
BBA
14
Baker Bros. Advisors
New York
$96M -$5.26M -33,528 -5%
EAM
15
Eagle Asset Management
Florida
$91.3M -$5.06M -32,231 -5%
Franklin Resources
16
Franklin Resources
California
$89.5M +$12.4M +79,241 +16%
Lord, Abbett & Co
17
Lord, Abbett & Co
New Jersey
$84.7M +$11.5M +73,024 +16%
MWNA
18
Marshall Wace North America
New York
$82.6M -$16.4M -104,484 -17%
American Century Companies
19
American Century Companies
Missouri
$82.5M +$32.2M +204,831 +64%
Victory Capital Management
20
Victory Capital Management
Texas
$74.5M +$6.41M +40,850 +9%
AllianceBernstein
21
AllianceBernstein
Tennessee
$71.8M -$11.8M -74,921 -14%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$68.1M +$1.15M +7,357 +2%
CTA
23
Carillon Tower Advisers
Florida
$67.6M -$3.04M -19,374 -4%
Goldman Sachs
24
Goldman Sachs
New York
$66.2M +$15.4M +98,206 +30%
PAMU
25
Pictet Asset Management (UK)
United Kingdom
$59.7M -$1.29M -8,188 -2%